Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host Disease
Clinical trial NCT02524847 · TERMINATED
Trial details
- NCT number
- NCT02524847
- Sponsor
- Therakos, Inc., a Mallinckrodt Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-20
- Primary completion
- 2019-07-16
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.